Position in GSK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$225,772
-$11,931 QoQ
Shares Held
4,307
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#685
of 1,033 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Saxony Capital Management, LLC holds $4,819,156 across 7 Drug Manufacturers - General names. GSK ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,303 | $2,762,287 | |
| 2 | ABBV |
AbbVie Inc.
|
2,538 | $638,662 | |
| 3 | JNJ |
Johnson & Johnson
|
1,989 | $505,146 | |
| 4 | AZN |
Astrazeneca PLC
|
1,275 | $241,765 | |
| 5 | AMGN |
Amgen Inc
|
625 | $226,325 | |
| 6 | GSK |
GSK plc
This page
|
4,307 | $225,772 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,735 | $219,199 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,772 | 4,307 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $237,703 | 4,307 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $208,272 | 4,247 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||